Press releases

Puneet Sarin Named President of Medication Management Solutions Steve Conly Named President of Biosciences FRANKLIN LAKES, N.J. (Sept. 8, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX),...

Mike Garrison Named EVP and President, Medical segment Rick Byrd Named EVP and President, Interventional segment FRANKLIN LAKES, N.J., Aug. 25, 2022 /PRNewswire/ -- BD (Becton, Dickinson and...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2022 Healthcare Conference on Wednesday,...

Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announced Tender Offers (as defined below) to purchase...

Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash...

First patient enrollment in PREVISION trial marks opportunity to further advance the safety and performance of drug-coated balloon technology and aligns with the company’s commitment to...

Companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide FRANKLIN LAKES, N.J. and TUCSON, Ariz., Aug. 15,...

Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseases FRANKLIN LAKES, N.J., Aug. 9, 2022 /PRNewswire/ -- BD...

Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the...

Funding to Four Community Health Centers Advances Medication Management Programs for Vulnerable Patients Managing Chronic Disease FRANKLIN LAKES, N.J., Aug. 8, 2022 /PRNewswire/ -- BD (Becton,...

Revenue from continuing operations of $4.6 billion increased 0.7% as reported and 3.8% on currency-neutral basis Revenue from continuing operations driven by base revenue growth of 6.0% as...

Acquisition adds to company's recent growth in high-technology pharmacy solutions and further accelerates the company's commitment to Smart, Connected Care – offering a customizable platform to...

Research Use Only (RUO) assay now available for BD MAX™ System users FRANKLIN LAKES, N.J., July 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, payable on September 30, 2022 to holders of record on...

Top Score on Disability Equality Index Demonstrates Progress in Removing Barriers and Creating Employment Opportunities for People with Disabilities FRANKLIN LAKES, N.J., July 20, 2022...

FRANKLIN LAKES, N.J. (July 19, 2022) — Recent research published in the Journal of the American College of Clinical Pharmacy shows that investments made in clinical pharmacist-led patient care...

- BD enters growing pharmacy automation market segment by offering a comprehensive set of technologies across the care continuum - Addition of Parata aligns with two key tenets of BD's innovation...

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its third quarter of fiscal year 2022 on Thursday, August 4, 2022. A news release will be...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated...

Company makes notable progress toward 2030+ ESG commitments, addressing energy, water and waste reduction, environmental impact of product portfolio and supplier diversification FRANKLIN LAKES, N.J.,

BD MAX™ Molecular Diagnostic Respiratory Viral Panel CE Marked to IVD Directive FRANKLIN LAKES, N.J., June 30, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today unveiled findings from a survey conducted by The Harris...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on the BD™ Intraosseous Needle Set Kits, BD™ Intraosseous Manual Driver Kits and...

BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world's largest collection of clinical data FRANKLIN LAKES, N.J., June 13, 2022 /PRNewswire/...

CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit ZARAGOZA, Spain and FRANKLIN LAKES, N.J., June 8, 2022 /PRNewswire/ --...